Comparison of BMSs with SES for Symptomatic Intracranial Disease of the Middle Cerebral Artery Stenosis
This study was designed to compare the clinical and angiographic outcomes of patients with symptomatic atherosclerotic middle cerebral artery stenosis treated with balloon-mounted stents (BMS) and self-expandable Wingspan system (SES). We reviewed the 69 consecutive stent placement procedures for sy...
Gespeichert in:
| Veröffentlicht in: | Cardiovascular and interventional radiology 2011-02, Vol.34 (1), p.54-60 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 60 |
|---|---|
| container_issue | 1 |
| container_start_page | 54 |
| container_title | Cardiovascular and interventional radiology |
| container_volume | 34 |
| creator | Yue, Xuanye Yin, Qin Xi, Gangming Zhu, Wusheng Xu, Gelin Zhang, Renliang Zhou, Zhiming Ma, Minmin Jin, Guangfu Liu, Xinfeng |
| description | This study was designed to compare the clinical and angiographic outcomes of patients with symptomatic atherosclerotic middle cerebral artery stenosis treated with balloon-mounted stents (BMS) and self-expandable Wingspan system (SES). We reviewed the 69 consecutive stent placement procedures for symptomatic atherosclerotic stenosis (≥70) in M1 segment of middle cerebral artery in 67 patients in 3 years. According to the stent types, the patients were classed as BMS and SES groups. The demographic characteristics, conventional risk factors of ischemic stroke, degree of stenosis, periprocedural complications, stent types, and clinical and angiographic outcomes were analyzed. There were 39 patients in the BMS group and 28 patients in the SES group. The demographic characteristics, conventional risk factors, and periprocedural complications were similar but different in residual stenosis after stenting in both groups (5.9% ± 9.9% vs. 14.4% ± 14.6%;
P
= 0.01). For the overall cohort, the rate of stroke or death and restenosis was 10.9% (7/66) and 24.5% (14/57), respectively. The frequency of restenosis was higher in the SES group than in the BMS group (log-rank,
P
= 0.04; crude hazard ratio = 3.03; 95% confidence interval (CI), 1.01–9.15;
P
= 0.049; and adjusted hazard ratio = 3.61; 95% CI, 1.06–12.27;
P
= 0.04); however, there was no difference in clinical outcomes (log-rank,
P
= 0.51; crude hazard ratio = 1.66; 95% CI, 0.36–7.61;
P
= 0.51; and adjusted hazard ratio = 0.59; 95% CI, 0.04–7.89;
P
= 0.69). The corrected degree of restenosis was higher in the SES than the BMS group. The prevalence of restenosis was higher in the SES than the BMS group, but the perioperative complications and follow-up clinical outcomes had no significant difference. |
| doi_str_mv | 10.1007/s00270-010-9885-z |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_21608819</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>954617381</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-30a1c694cf2602892635694e8b24c61c40866c288c45644b1401585e8c6cb8423</originalsourceid><addsrcrecordid>eNqFkVFrFDEUhYModq3-AF8k6EOfRm8ySSbzWNeqhRYfRsG3kMne6abMTNYki2x_fbNMVRBE7kO43O-ccDiEvGTwlgE07xIAb6ACBlWrtazuHpEVEzWvQKvvj8kKWCMqJiU7Ic9SugVgUnP5lJxwEFKXWZGbdZh2NvoUZhoG-v66S_Snz1vaXXR0CJF2h2mXw2Szd_RyztG6aGdvR_rBJ7QJj6q8RXrtN5sR6Roj9rGcz2PGeKBdxjkkn56TJ4MdE754eE_Jt48XX9efq6svny7X51eVEzXkqgbLnGqFG7gCrluuallW1D0XTjEnSjLluNZOSCVEz8Qxk0TtlOu14PUpebP4hpS9Sc5ndFsX5hldNpwp0Jq1hTpbqF0MP_aYspl8cjiOdsawT6aVQrGm1uy_pBZQC90oUcjXf5G3YR_nEtboumWCaWgKxBbIxZBSxMHsop9sPBgG5tipWTo1pVNz7NTcFc2rB-N9P-Hmt-JXiQXgC5DKab7B-Ofnf7veAziJqX8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>839141807</pqid></control><display><type>article</type><title>Comparison of BMSs with SES for Symptomatic Intracranial Disease of the Middle Cerebral Artery Stenosis</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Yue, Xuanye ; Yin, Qin ; Xi, Gangming ; Zhu, Wusheng ; Xu, Gelin ; Zhang, Renliang ; Zhou, Zhiming ; Ma, Minmin ; Jin, Guangfu ; Liu, Xinfeng</creator><creatorcontrib>Yue, Xuanye ; Yin, Qin ; Xi, Gangming ; Zhu, Wusheng ; Xu, Gelin ; Zhang, Renliang ; Zhou, Zhiming ; Ma, Minmin ; Jin, Guangfu ; Liu, Xinfeng</creatorcontrib><description>This study was designed to compare the clinical and angiographic outcomes of patients with symptomatic atherosclerotic middle cerebral artery stenosis treated with balloon-mounted stents (BMS) and self-expandable Wingspan system (SES). We reviewed the 69 consecutive stent placement procedures for symptomatic atherosclerotic stenosis (≥70) in M1 segment of middle cerebral artery in 67 patients in 3 years. According to the stent types, the patients were classed as BMS and SES groups. The demographic characteristics, conventional risk factors of ischemic stroke, degree of stenosis, periprocedural complications, stent types, and clinical and angiographic outcomes were analyzed. There were 39 patients in the BMS group and 28 patients in the SES group. The demographic characteristics, conventional risk factors, and periprocedural complications were similar but different in residual stenosis after stenting in both groups (5.9% ± 9.9% vs. 14.4% ± 14.6%;
P
= 0.01). For the overall cohort, the rate of stroke or death and restenosis was 10.9% (7/66) and 24.5% (14/57), respectively. The frequency of restenosis was higher in the SES group than in the BMS group (log-rank,
P
= 0.04; crude hazard ratio = 3.03; 95% confidence interval (CI), 1.01–9.15;
P
= 0.049; and adjusted hazard ratio = 3.61; 95% CI, 1.06–12.27;
P
= 0.04); however, there was no difference in clinical outcomes (log-rank,
P
= 0.51; crude hazard ratio = 1.66; 95% CI, 0.36–7.61;
P
= 0.51; and adjusted hazard ratio = 0.59; 95% CI, 0.04–7.89;
P
= 0.69). The corrected degree of restenosis was higher in the SES than the BMS group. The prevalence of restenosis was higher in the SES than the BMS group, but the perioperative complications and follow-up clinical outcomes had no significant difference.</description><identifier>ISSN: 0174-1551</identifier><identifier>EISSN: 1432-086X</identifier><identifier>DOI: 10.1007/s00270-010-9885-z</identifier><identifier>PMID: 20458585</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject>Angioplasty, Balloon - instrumentation ; ARTERIES ; BLOOD VESSELS ; BODY ; Cardiology ; CARDIOVASCULAR SYSTEM ; Cerebral Angiography ; CEREBRAL ARTERIES ; Chi-Square Distribution ; Clinical Investigation ; COMPARATIVE EVALUATIONS ; DISEASES ; EVALUATION ; Female ; HAZARDS ; Humans ; Imaging ; Intracranial Arteriosclerosis - complications ; Intracranial Arteriosclerosis - diagnostic imaging ; Intracranial Arteriosclerosis - mortality ; Intracranial Arteriosclerosis - therapy ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Middle Cerebral Artery ; Nuclear Medicine ; ORGANS ; PATIENTS ; Prevalence ; Proportional Hazards Models ; Radiology ; RADIOLOGY AND NUCLEAR MEDICINE ; Recurrence ; Registries ; Risk Factors ; Stents ; Survival Rate ; Treatment Outcome ; Ultrasound</subject><ispartof>Cardiovascular and interventional radiology, 2011-02, Vol.34 (1), p.54-60</ispartof><rights>Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2010</rights><rights>Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-30a1c694cf2602892635694e8b24c61c40866c288c45644b1401585e8c6cb8423</citedby><cites>FETCH-LOGICAL-c430t-30a1c694cf2602892635694e8b24c61c40866c288c45644b1401585e8c6cb8423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00270-010-9885-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00270-010-9885-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20458585$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/21608819$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Yue, Xuanye</creatorcontrib><creatorcontrib>Yin, Qin</creatorcontrib><creatorcontrib>Xi, Gangming</creatorcontrib><creatorcontrib>Zhu, Wusheng</creatorcontrib><creatorcontrib>Xu, Gelin</creatorcontrib><creatorcontrib>Zhang, Renliang</creatorcontrib><creatorcontrib>Zhou, Zhiming</creatorcontrib><creatorcontrib>Ma, Minmin</creatorcontrib><creatorcontrib>Jin, Guangfu</creatorcontrib><creatorcontrib>Liu, Xinfeng</creatorcontrib><title>Comparison of BMSs with SES for Symptomatic Intracranial Disease of the Middle Cerebral Artery Stenosis</title><title>Cardiovascular and interventional radiology</title><addtitle>Cardiovasc Intervent Radiol</addtitle><addtitle>Cardiovasc Intervent Radiol</addtitle><description>This study was designed to compare the clinical and angiographic outcomes of patients with symptomatic atherosclerotic middle cerebral artery stenosis treated with balloon-mounted stents (BMS) and self-expandable Wingspan system (SES). We reviewed the 69 consecutive stent placement procedures for symptomatic atherosclerotic stenosis (≥70) in M1 segment of middle cerebral artery in 67 patients in 3 years. According to the stent types, the patients were classed as BMS and SES groups. The demographic characteristics, conventional risk factors of ischemic stroke, degree of stenosis, periprocedural complications, stent types, and clinical and angiographic outcomes were analyzed. There were 39 patients in the BMS group and 28 patients in the SES group. The demographic characteristics, conventional risk factors, and periprocedural complications were similar but different in residual stenosis after stenting in both groups (5.9% ± 9.9% vs. 14.4% ± 14.6%;
P
= 0.01). For the overall cohort, the rate of stroke or death and restenosis was 10.9% (7/66) and 24.5% (14/57), respectively. The frequency of restenosis was higher in the SES group than in the BMS group (log-rank,
P
= 0.04; crude hazard ratio = 3.03; 95% confidence interval (CI), 1.01–9.15;
P
= 0.049; and adjusted hazard ratio = 3.61; 95% CI, 1.06–12.27;
P
= 0.04); however, there was no difference in clinical outcomes (log-rank,
P
= 0.51; crude hazard ratio = 1.66; 95% CI, 0.36–7.61;
P
= 0.51; and adjusted hazard ratio = 0.59; 95% CI, 0.04–7.89;
P
= 0.69). The corrected degree of restenosis was higher in the SES than the BMS group. The prevalence of restenosis was higher in the SES than the BMS group, but the perioperative complications and follow-up clinical outcomes had no significant difference.</description><subject>Angioplasty, Balloon - instrumentation</subject><subject>ARTERIES</subject><subject>BLOOD VESSELS</subject><subject>BODY</subject><subject>Cardiology</subject><subject>CARDIOVASCULAR SYSTEM</subject><subject>Cerebral Angiography</subject><subject>CEREBRAL ARTERIES</subject><subject>Chi-Square Distribution</subject><subject>Clinical Investigation</subject><subject>COMPARATIVE EVALUATIONS</subject><subject>DISEASES</subject><subject>EVALUATION</subject><subject>Female</subject><subject>HAZARDS</subject><subject>Humans</subject><subject>Imaging</subject><subject>Intracranial Arteriosclerosis - complications</subject><subject>Intracranial Arteriosclerosis - diagnostic imaging</subject><subject>Intracranial Arteriosclerosis - mortality</subject><subject>Intracranial Arteriosclerosis - therapy</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Middle Cerebral Artery</subject><subject>Nuclear Medicine</subject><subject>ORGANS</subject><subject>PATIENTS</subject><subject>Prevalence</subject><subject>Proportional Hazards Models</subject><subject>Radiology</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>Recurrence</subject><subject>Registries</subject><subject>Risk Factors</subject><subject>Stents</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>Ultrasound</subject><issn>0174-1551</issn><issn>1432-086X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkVFrFDEUhYModq3-AF8k6EOfRm8ySSbzWNeqhRYfRsG3kMne6abMTNYki2x_fbNMVRBE7kO43O-ccDiEvGTwlgE07xIAb6ACBlWrtazuHpEVEzWvQKvvj8kKWCMqJiU7Ic9SugVgUnP5lJxwEFKXWZGbdZh2NvoUZhoG-v66S_Snz1vaXXR0CJF2h2mXw2Szd_RyztG6aGdvR_rBJ7QJj6q8RXrtN5sR6Roj9rGcz2PGeKBdxjkkn56TJ4MdE754eE_Jt48XX9efq6svny7X51eVEzXkqgbLnGqFG7gCrluuallW1D0XTjEnSjLluNZOSCVEz8Qxk0TtlOu14PUpebP4hpS9Sc5ndFsX5hldNpwp0Jq1hTpbqF0MP_aYspl8cjiOdsawT6aVQrGm1uy_pBZQC90oUcjXf5G3YR_nEtboumWCaWgKxBbIxZBSxMHsop9sPBgG5tipWTo1pVNz7NTcFc2rB-N9P-Hmt-JXiQXgC5DKab7B-Ofnf7veAziJqX8</recordid><startdate>20110201</startdate><enddate>20110201</enddate><creator>Yue, Xuanye</creator><creator>Yin, Qin</creator><creator>Xi, Gangming</creator><creator>Zhu, Wusheng</creator><creator>Xu, Gelin</creator><creator>Zhang, Renliang</creator><creator>Zhou, Zhiming</creator><creator>Ma, Minmin</creator><creator>Jin, Guangfu</creator><creator>Liu, Xinfeng</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7TK</scope><scope>OTOTI</scope></search><sort><creationdate>20110201</creationdate><title>Comparison of BMSs with SES for Symptomatic Intracranial Disease of the Middle Cerebral Artery Stenosis</title><author>Yue, Xuanye ; Yin, Qin ; Xi, Gangming ; Zhu, Wusheng ; Xu, Gelin ; Zhang, Renliang ; Zhou, Zhiming ; Ma, Minmin ; Jin, Guangfu ; Liu, Xinfeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-30a1c694cf2602892635694e8b24c61c40866c288c45644b1401585e8c6cb8423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Angioplasty, Balloon - instrumentation</topic><topic>ARTERIES</topic><topic>BLOOD VESSELS</topic><topic>BODY</topic><topic>Cardiology</topic><topic>CARDIOVASCULAR SYSTEM</topic><topic>Cerebral Angiography</topic><topic>CEREBRAL ARTERIES</topic><topic>Chi-Square Distribution</topic><topic>Clinical Investigation</topic><topic>COMPARATIVE EVALUATIONS</topic><topic>DISEASES</topic><topic>EVALUATION</topic><topic>Female</topic><topic>HAZARDS</topic><topic>Humans</topic><topic>Imaging</topic><topic>Intracranial Arteriosclerosis - complications</topic><topic>Intracranial Arteriosclerosis - diagnostic imaging</topic><topic>Intracranial Arteriosclerosis - mortality</topic><topic>Intracranial Arteriosclerosis - therapy</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Middle Cerebral Artery</topic><topic>Nuclear Medicine</topic><topic>ORGANS</topic><topic>PATIENTS</topic><topic>Prevalence</topic><topic>Proportional Hazards Models</topic><topic>Radiology</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>Recurrence</topic><topic>Registries</topic><topic>Risk Factors</topic><topic>Stents</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yue, Xuanye</creatorcontrib><creatorcontrib>Yin, Qin</creatorcontrib><creatorcontrib>Xi, Gangming</creatorcontrib><creatorcontrib>Zhu, Wusheng</creatorcontrib><creatorcontrib>Xu, Gelin</creatorcontrib><creatorcontrib>Zhang, Renliang</creatorcontrib><creatorcontrib>Zhou, Zhiming</creatorcontrib><creatorcontrib>Ma, Minmin</creatorcontrib><creatorcontrib>Jin, Guangfu</creatorcontrib><creatorcontrib>Liu, Xinfeng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>OSTI.GOV</collection><jtitle>Cardiovascular and interventional radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yue, Xuanye</au><au>Yin, Qin</au><au>Xi, Gangming</au><au>Zhu, Wusheng</au><au>Xu, Gelin</au><au>Zhang, Renliang</au><au>Zhou, Zhiming</au><au>Ma, Minmin</au><au>Jin, Guangfu</au><au>Liu, Xinfeng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of BMSs with SES for Symptomatic Intracranial Disease of the Middle Cerebral Artery Stenosis</atitle><jtitle>Cardiovascular and interventional radiology</jtitle><stitle>Cardiovasc Intervent Radiol</stitle><addtitle>Cardiovasc Intervent Radiol</addtitle><date>2011-02-01</date><risdate>2011</risdate><volume>34</volume><issue>1</issue><spage>54</spage><epage>60</epage><pages>54-60</pages><issn>0174-1551</issn><eissn>1432-086X</eissn><abstract>This study was designed to compare the clinical and angiographic outcomes of patients with symptomatic atherosclerotic middle cerebral artery stenosis treated with balloon-mounted stents (BMS) and self-expandable Wingspan system (SES). We reviewed the 69 consecutive stent placement procedures for symptomatic atherosclerotic stenosis (≥70) in M1 segment of middle cerebral artery in 67 patients in 3 years. According to the stent types, the patients were classed as BMS and SES groups. The demographic characteristics, conventional risk factors of ischemic stroke, degree of stenosis, periprocedural complications, stent types, and clinical and angiographic outcomes were analyzed. There were 39 patients in the BMS group and 28 patients in the SES group. The demographic characteristics, conventional risk factors, and periprocedural complications were similar but different in residual stenosis after stenting in both groups (5.9% ± 9.9% vs. 14.4% ± 14.6%;
P
= 0.01). For the overall cohort, the rate of stroke or death and restenosis was 10.9% (7/66) and 24.5% (14/57), respectively. The frequency of restenosis was higher in the SES group than in the BMS group (log-rank,
P
= 0.04; crude hazard ratio = 3.03; 95% confidence interval (CI), 1.01–9.15;
P
= 0.049; and adjusted hazard ratio = 3.61; 95% CI, 1.06–12.27;
P
= 0.04); however, there was no difference in clinical outcomes (log-rank,
P
= 0.51; crude hazard ratio = 1.66; 95% CI, 0.36–7.61;
P
= 0.51; and adjusted hazard ratio = 0.59; 95% CI, 0.04–7.89;
P
= 0.69). The corrected degree of restenosis was higher in the SES than the BMS group. The prevalence of restenosis was higher in the SES than the BMS group, but the perioperative complications and follow-up clinical outcomes had no significant difference.</abstract><cop>New York</cop><pub>Springer-Verlag</pub><pmid>20458585</pmid><doi>10.1007/s00270-010-9885-z</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0174-1551 |
| ispartof | Cardiovascular and interventional radiology, 2011-02, Vol.34 (1), p.54-60 |
| issn | 0174-1551 1432-086X |
| language | eng |
| recordid | cdi_osti_scitechconnect_21608819 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Angioplasty, Balloon - instrumentation ARTERIES BLOOD VESSELS BODY Cardiology CARDIOVASCULAR SYSTEM Cerebral Angiography CEREBRAL ARTERIES Chi-Square Distribution Clinical Investigation COMPARATIVE EVALUATIONS DISEASES EVALUATION Female HAZARDS Humans Imaging Intracranial Arteriosclerosis - complications Intracranial Arteriosclerosis - diagnostic imaging Intracranial Arteriosclerosis - mortality Intracranial Arteriosclerosis - therapy Male Medicine Medicine & Public Health Middle Aged Middle Cerebral Artery Nuclear Medicine ORGANS PATIENTS Prevalence Proportional Hazards Models Radiology RADIOLOGY AND NUCLEAR MEDICINE Recurrence Registries Risk Factors Stents Survival Rate Treatment Outcome Ultrasound |
| title | Comparison of BMSs with SES for Symptomatic Intracranial Disease of the Middle Cerebral Artery Stenosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T14%3A10%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20BMSs%20with%20SES%20for%20Symptomatic%20Intracranial%20Disease%20of%20the%20Middle%20Cerebral%20Artery%20Stenosis&rft.jtitle=Cardiovascular%20and%20interventional%20radiology&rft.au=Yue,%20Xuanye&rft.date=2011-02-01&rft.volume=34&rft.issue=1&rft.spage=54&rft.epage=60&rft.pages=54-60&rft.issn=0174-1551&rft.eissn=1432-086X&rft_id=info:doi/10.1007/s00270-010-9885-z&rft_dat=%3Cproquest_osti_%3E954617381%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=839141807&rft_id=info:pmid/20458585&rfr_iscdi=true |